1. Home
  2. HOFT vs VTVT Comparison

HOFT vs VTVT Comparison

Compare HOFT & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$12.34

Market Cap

144.6M

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$31.47

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOFT
VTVT
Founded
1924
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.6M
148.7M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
HOFT
VTVT
Price
$12.34
$31.47
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$53.00
AVG Volume (30 Days)
35.8K
51.6K
Earning Date
04-16-2026
05-07-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$278,139,000.00
N/A
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.46
$14.00
52 Week High
$15.99
$44.00

Technical Indicators

Market Signals
Indicator
HOFT
VTVT
Relative Strength Index (RSI) 42.08 39.53
Support Level $12.15 $30.62
Resistance Level $13.47 $33.11
Average True Range (ATR) 0.88 2.70
MACD -0.16 -0.84
Stochastic Oscillator 13.65 21.67

Price Performance

Historical Comparison
HOFT
VTVT

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: